Pregled bibliografske jedinice broj: 314222
Clonal Dissemination of Highly Virulent Extended-Spectrum Beta Lactamase-Producing Escherichia coli Strains Isolated From the Urine of Non-Hospitalised Patients in Zagreb Region
Clonal Dissemination of Highly Virulent Extended-Spectrum Beta Lactamase-Producing Escherichia coli Strains Isolated From the Urine of Non-Hospitalised Patients in Zagreb Region // International Journal of Antimicrobial Agents, 31 (2008), Supplement 1; 19-24 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 314222 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Clonal Dissemination of Highly Virulent Extended-Spectrum Beta Lactamase-Producing Escherichia coli Strains Isolated From the Urine of Non-Hospitalised Patients in Zagreb Region
Autori
Vraneš, Jasmina ; Marijan, Tatjana ; Bedenić, Branka ; Mlinarić-Džepina, Ana ; Katić, Stjepan ; Kalenić, Smilja
Izvornik
International Journal of Antimicrobial Agents (0924-8579) 31
(2008), Supplement 1;
19-24
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
community-acquired urinary tract infections; extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli; clonal dissemination
Sažetak
Recent data suggest that extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli is an emergent cause of urinary tract infections in non-hospitalised patients in different countries. The aim of this study was to characterise ESBL-producing E.coli strains isolated from the urine of outpatients in the Zagreb region of Croatia. During the 5-month study period, a total of 2451 E. coli strains were isolated from the urine of non-hospitalised patients with significant bacteriuria. A total of 39 ESBL-producing E.coli strains (1.59%) were collected and characterised.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti, Javno zdravstvo i zdravstvena zaštita
Napomena
Urinary Tract Infections Supplement, International Symposia on Urinary Tract Infection Weimar and Munich, Germany Edited by K.G. Naber, T. Matsumoto, L. Nicolle and R. Funfstuck Astellas Pharmaceutical Co. Ltd, Daiichi Pharmaceutical Co. Ltd, Dainippon Sumitomo Pharmaceutical Co. Ltd, Meiji Seika Kaisha and Takeda Chemical Industries Ltd, Toyamakagaku Pharmaceuticals and Zambon Group Spa. This supplement of the International Journal of Antimicrobial Agents deals with an update of current concepts of the diagnosis and treatment of urinary tract infections (UTI) and prostatitis based on two symposia in June 2006 in Weimar, Germany, and during the 25th International Congress of Chemotherapy in cooperation with the 17th European Congress of Clinical Microbiology and Infectious Diseases 30 March– 3 April 2007 in Munich, Germany
POVEZANOST RADA
Projekti:
108-1080 114-0017
108-1080114-0015 - Mehanizmi rezistencije na antibiotike u Gram-negativnih bakterija (Bedenić, Branka, MZOS ) ( CroRIS)
108-1080114-0017 - Genotipovi i činitelji virulencije uzročnika bolničkih infekcija (Budimir, Ana, MZOS ) ( CroRIS)
121-1080114-0306 - Djelovanje antibiotika na uzročnike biofilm infekcija (Vraneš, Jasmina, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb,
Nastavni zavod za javno zdravstvo "Dr. Andrija Štampar",
Klinički bolnički centar Zagreb
Profili:
Branka Bedenić
(autor)
Tatjana Marijan
(autor)
Smilja Kalenić
(autor)
Stjepan Katić
(autor)
Jasmina Vraneš
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- Excerpta Medica
- Index Medicus